# Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections

> **NCT06774638** · — · COMPLETED · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 36 (actual)

## Conditions studied

- IBD - Inflammatory Bowel Disease
- COVID - 19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06774638
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-04
- **Primary completion:** 2021-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774638, "Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06774638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*